ADVISORY RESEARCH INC - SUPERNUS PHARMACEUTICALS INC ownership

SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 240 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.2%.

Quarter-by-quarter ownership
ADVISORY RESEARCH INC ownership history of SUPERNUS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$483,523
-11.1%
17,538
-3.1%
0.07%
-4.3%
Q2 2023$543,846
-13.6%
18,092
+4.1%
0.07%
-32.0%
Q1 2023$629,641
+2.9%
17,379
+1.3%
0.10%
+77.6%
Q4 2022$612,169
-32.4%
17,162
-35.8%
0.06%
-34.1%
Q3 2022$905,000
+17.5%
26,724
+0.3%
0.09%
+17.3%
Q2 2022$770,000
-1.7%
26,631
+9.9%
0.08%
+19.0%
Q1 2022$783,00024,2310.06%
Other shareholders
SUPERNUS PHARMACEUTICALS INC shareholders Q3 2022
NameSharesValueWeighting ↓
ASHFORD CAPITAL MANAGEMENT INC 698,676$41,816,0005.51%
Provident Investment Management, Inc. 543,194$32,510,0004.61%
NEUMEIER POMA INVESTMENT COUNSEL LLC 426,250$25,511,0002.37%
KOPP INVESTMENT ADVISORS LLC 41,879$2,506,0002.35%
AlphaOne Investment Services, LLC 126,279$7,558,0002.17%
Ranger Investment Management 468,933$28,066,0001.96%
Bruce & Co., Inc. 158,058$9,459,0001.88%
Penserra Capital Management LLC 244,371$29,030,0001.83%
SHAKER INVESTMENTS LLC/OH 49,642$2,971,0001.83%
Bridge City Capital, LLC 47,795$2,861,0001.81%
View complete list of SUPERNUS PHARMACEUTICALS INC shareholders